Journey Strategic Wealth LLC Novo Nordisk A S Transaction History
Journey Strategic Wealth LLC
- $2.25 Billion
- Q1 2024
A detailed history of Journey Strategic Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 6,792 shares of NVO stock, worth $971,120. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,792
Previous 3,573
90.09%
Holding current value
$971,120
Previous $369,000
136.31%
% of portfolio
0.04%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,856Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.01 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.96 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.87 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.72 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.69 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $323B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...